Ornithine Transcarbamylase Deficiency

Ornithine Transcarbamylase Deficiency is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Ornithine Carbamoyltransferase Deficiency Disease · Ornithine transcarbamoylase deficiency · Ornithine Transcarbamylase Deficiency Disease · Ornithine Carbamoyltransferase Deficiency · Ornithine Transcarbamylase (OTC) Deficiency
Indicated drugs

Resolves to

Vocabularies
MeSHM0328321ICD-10E72.4SNOMED CT124249000MedDRA10052450UMLSC0268542

What you can answer from here — as of November 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
21Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Ornithine Transcarbamylase Deficiency share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.

Create Account